Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.
2.

Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).

Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA.

Med Care. 2007 Oct;45(10 Supl 2):S96-102.

PMID:
17909391
3.
5.

Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.

Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL.

Ann Emerg Med. 2005 Feb;45(2):197-206.

PMID:
15671977
6.

National estimates of nonfatal injuries treated in hospital emergency departments--United States, 2000.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2001 May 4;50(17):340-6.

7.
8.

Nonfatal self-inflicted injuries treated in hospital emergency departments--United States, 2000.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2002 May 24;51(20):436-8.

9.

Epidemiology, comparative methods of detection, and preventability of adverse drug events.

Al-Tajir GK, Kelly WN.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1169-74.

PMID:
15928265
10.

The epidemiology of preventable adverse drug events: a review of the literature.

von Laue NC, Schwappach DL, Koeck CM.

Wien Klin Wochenschr. 2003 Jul 15;115(12):407-15. Review.

PMID:
12918183
11.

Adverse drug event reporting in intensive care units: a survey of current practices.

Kane-Gill SL, Devlin JW.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1267-73.

PMID:
16849619
12.

Evaluation of a computer-based adverse-drug-event monitor.

Hwang SH, Lee S, Koo HK, Kim Y.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2265-72. doi: 10.2146/ajhp080122.

PMID:
19020194
13.

Nonfatal physical assault-related injuries treated in hospital emergency departments--United States, 2000.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2002 May 31;51(21):460-3.

14.

Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System.

Ross MP, Ferguson M, Street D, Klontz K, Schroeder T, Luccioli S.

J Allergy Clin Immunol. 2008 Jan;121(1):166-71. doi: 10.1016/j.jaci.2007.10.012.

PMID:
18206508
15.

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R.

Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275-84.

PMID:
17955500
16.

A pharmaceutical manufacturer's perspective on reporting adverse drug experiences.

Sullivan JW.

Am J Hosp Pharm. 1990 Jun;47(6):1342-5.

PMID:
2368728
17.

Medication safety program reduces adverse drug events in a community hospital.

Cohen MM, Kimmel NL, Benage MK, Cox MJ, Sanders N, Spence D, Chen J.

Qual Saf Health Care. 2005 Jun;14(3):169-74.

18.

Adverse-drug-event data provided by pharmaceutical companies.

Cudny ME, Graham AS.

Am J Health Syst Pharm. 2008 Jun 1;65(11):1071-5. doi: 10.2146/ajhp070453.

PMID:
18499882
19.

Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.

Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M.

Res Social Adm Pharm. 2011 Dec;7(4):369-82. doi: 10.1016/j.sapharm.2010.09.001.

PMID:
21272531
20.

Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.

Ferranti J, Horvath MM, Cozart H, Whitehurst J, Eckstrand J.

Pediatrics. 2008 May;121(5):e1201-7. doi: 10.1542/peds.2007-2609.

PMID:
18450863
Items per page

Supplemental Content

Support Center